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ABSTRACT It is not definitively known whether the highly conserved region of myosin heavy chain around SH, (Cys 707) is part of the
actin-binding site. We tested this possibility by assaying for competitive inhibition of maximum Ca-activated force production of
skinned muscle fibers by synthetic peptides which had sequences derived from the SH, region of myosin. Force was inhibited by a
heptapeptide (IRICRKG) with an apparent K05 of about 4 mM. Unloaded shortening velocity of fibers, determined by the slack test,
and maximum Ca-activated myofibrillar MgATPase activity were also inhibited by this peptide, but both required higher
concentrations. We found that other cationic peptides also inhibited force in a manner that depended on the charge of the peptide;
increasing the net positive charge of the peptide increased its efficacy. The inhibition was not significantly affected by altering
solution ionic strength (100-200 mM). Disulfide bond formation was not involved in the inhibitory mechanism because a peptide
with Thr substituted for Cys was inhibitory in the presence or absence of DTT. Our data demonstrate that the net charge was the
predominant molecular characteristic correlated with the ability of peptides from this region of myosin heavy chain to inhibit force
production. Thus, the hypothesis that the SH, region of myosin is an essential part of the force-producing interaction with actin
during the cross-bridge cycle (Eto, M., R. Suzuki, F. Morita, H. Kuwayama, N. Nishi, and S. Tokura., 1990, J. Biochem.
108:499-504; Keane et al., 1990, Nature (Lond.). 344:265-268) is not supported.
INTRODUCTION
To determine the molecular mechanism of chemome-
chanical energy transduction by actomyosin, it will be
necessary to know the specific amino acids in the myosin
primary sequence which contact actin and how the
interactions at the actomyosin interface change during
the cross-bridge cycle. Three regions of MHC1 primary
sequence have been tentatively identified as actin-
binding sites (reviewed by Mornet et al., 1989; Botts et
al., 1989; Audemard et al., 1988). Biochemical studies,
using a variety of methods, have localized one site at the
junction of the 50-kD and 20-kD tryptic fragments and
the immediately adjacent COOH-terminus of the 20-kD
fragment (Eldin et al., 1990; Kasprzak et al., 1989;
Bertrand et al., 1988; Chaussepied and Morales, 1988;
Sutoh, 1982, 1983; Mornet et al., 1981a, b). But this is
not the entire actin-binding site (Chaussepied and
Kasprzak, 1989; Katoh and Morita, 1984). Chemical
cross-linking studies also implicate a second actin-
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binding region close to the COOH-terminus of the
50-kD tryptic fragment (Sutoh, 1983; Mornet et al.,
1981a, b). The existence of a third site which includes
the SH1 thiol (Cys 707) was proposed by Morita and
co-workers from studies of chemical modifications of the
Si fragment of myosin (Suzuki and Morita, 1987; Katoh
et al., 1985; Katoh et al., 1984; Katoh and Morita, 1984).
Further evidence supporting an actin-binding role of the
SH, region was obtained from nuclear magnetic reso-
nance (NMR) spectroscopy studies using S1 labeled at
SH, (Keane et al., 1990; Barden et al., 1989). Most
recently, synthetic peptides corresponding to the SH1
portion of the MHC primary sequence have been found
to bind to actin and competitively inhibit both formation
of acto-Sl rigor complex (Eto et al., 1990; Suzuki et al.,
1987) and actin-activated S1-ATPase activity (Keane et
al., 1990; Suzuki et al., 1990). However, there appears to
be a significant distance (5 nm) between SH, and the
actin-binding site measured by electron microscopy
(Tokunaga et al., 1987) and by fluorescence resonance
energy transfer (FRET) (Takashi and Kasprzak, 1987;
Dos Remedios and Cooke, 1984; Trayer and Trayer,
1983; Takashi, 1979). In addition, there is no evidence of
chemical cross-linking of the SH, region to actin (Betta-
che et al., 1989; Sutoh, 1982, 1983).
It is important to establish whether the SH, region of
MHC is part of the actin-binding site for interpretation
of existing data, such as the functional significance of
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motion of reporter groups covalently attached to SH,
(reviewed by Thomas, 1987), and to focus further
structure-function studies at the molecular level. We
approached the problem of whether SH, is at the actin
interface by testing, on skinned muscle fibers, for inhibi-
tory properties of synthetic peptides that correspond to
the SH, sequence of MHC. This is a logical extension of
this search for functional domains in the primary se-
quence of MHC, as described above (Eldin et al., 1990;
Keane et al., 1990; Suzuki et al., 1987; Katoh et al.,
1985). Skinned fibers make a useful assay system for
determining the physiological significance of putative
sites of interaction between actin and myosin, and they
have been studied with this in mind by Keane et al.
(1990). Small peptides (the peptides described herein
were on the order of 1 kD) can be used to probe the
actomyosin interaction in skinned fiber experiments,
because there are no membrane barriers to impede
diffusion throughout the myofilament lattice. As in living
muscle, the actomyosin interaction in skinned fibers is
structurally constrained by the myofilament lattice and
the exernal mechanical connections. Concomitant with
ATP hydrolysis, the actomyosin interaction is the basis
for, and is in turn influenced by, isometric force and
sliding of the thick and thin filaments, physiologically
relevant parameters that are not present or controlled in
most in vitro experiments. If actin-binding peptides
associate with, and thus block a part of actin which is
important for cross-bridge function, then force genera-
tion and movement by actomyosin should either be
partially or wholly inhibited. Inhibition should be evi-
dent whether the region probed is required for one step
in a sequence that leads to force generation (Huxley and
Simmons, 1971) or whether it is one of many regions
which together are responsible for generation of force.
This allowed a test of whether the SH, sequence in the
myosin head, which corresponds to actin-binding pep-
tides, is an essential part of the actin-binding site in the
native molecule.
Portions of this work have appeared elsewhere in
preliminary form (Chase et al., 1991; Chase and Kush-
merick, 1991; Chase et al., 1990).
MATERIALS AND METHODS
Skinned fibers
Single cell segments were dissected from bundles of glycerinated fibers
from rabbit psoas muscle (Chase and Kushmerick, 1988a). The ends of
the fiber segments were wrapped in aluminum foil "T-clips" (Goldman
and Simmons, 1984). Before insertion in the clips, the segment ends
were chemically fixed by microapplication of glutaraldehyde (5% in
H20, with 1 mg/ml Na-fluorescein); the dissection bath had 10 mg/ml
of soybean trypsin inhibitor added to restrict diffusion of the fixative.
The fiber segment was mounted in a bath at the focal plane of an
inverted microscope (Leitz, Wetzlar, Germany), with the clips at-
tached to hooks on a motor (General Scanning, Watertown, MA) at
one end and a force transducer (Cambridge Technology, Watertown,
MA) at the other end. Sarcomere length was monitored visually, both
in relaxing and activating solutions, and was also monitored by laser
diffraction in some experiments. The solution holders (100 or 300 >l)
were made of electroplated aluminum and had glass bottoms; the
temperature of the bath was maintained at 12°C using thermoelectric
chips (Cambion, Cambridge, MA). Solution changes were effected by
raising the fiber out of one bath allowing another bath to be rotated
under it, and lowering the fiber into the new bath.
During the experiment, the fiber segment was slackened every 5 s by
shortening the fiber at a rate approximately equal to the maximum
shortening velocity, and then rapidly restretching it to the original
length (Brenner, 1983). Force measurements or length steps (as in
determination of V.,) were performed during the steady-state period
between releases (Sweeney et al., 1987). Signals were low-pass filtered
(fc = 4 kHz) and records were digitized at rates of up to 12.5 kHz per
channel. Force and V.M measurements in the presence of peptide were
normalized to the average of bracketing control measurements made
before and after.
Solutions
The bathing solutions were made and the compositions calculated as
previously described (Chase and Kushmerick, 1988a). The standard
conditions were (mM) 5 MgATP, 15 PCr, 1 Pi, 4 EGTA, 50 DTT, 250
MOPS, ,. = 200 adjusted with acetate and Tris, 50 Na+, 50 K+, 3 Mg2",
pCa 4.0-4.5 (activating) or pCa > 8 (relaxing), pH 7.1, 250 U/ml CK,
12°C. In experiments where ,. was varied, the following changes were
made in all solutions, in addition to the variation in acetate and Tris: 4
MgATP, 10 PCr, 40 MOPS, 36.5 Na+, and 33.5 K+. No account was
taken of the peptides' contribution to p.. The solutions were made up
as concentrated stocks (1.5 times) and were diluted to final volume by
adding appropriate amounts of concentrated peptide solution (50
mg/ml) and H20.
Peptides
Peptides were synthesized by Applied Biosystems (Foster City, CA) or
by the Howard Hughes Chemical Synthesis Facility, University of
Washington (Seattle, WA). By convention, all peptide sequences are
given from NH2- to COOH-terminus; acetylation of the NH2-terminus
is indicated by Ac- and amidation of the COOH-terminus is indicated
by -NH2. For purification, a C18 300 A semipreparative RP-HPLC
column was used (model 201TP510, Vydac, Hespera, CA). The
peptides were dissolved in a two- to three-fold molar excess of both
DTT and MOPS (pH 7.0). Separation was achieved by an elution
gradient from 5-60% acetonitrile (ACN) in H20 with 0.1% trifluoro-
acetic acid (TEA). The fractions containing the correct peptide
sequence were collected in acid-washed glassware and lyophilized.
The lyophilized peptides were redissolved in 5% acetic acid and
identical fractions from several HPLC separations were combined and
lyophilized. Lyophilization was repeated once or twice more, dissolv-
ing the peptides in H20 until all fractions containing the same peptide
had been combined into one.
We verified that the peptides were not altered during the purifica-
tion procedure by the following criteria: (a) molecular mass and amino
acid composition for each peptide were the same as theoretical; (b)
retention time and purity of each peptide were checked by analytical
RP-HPLC (201TP54 Vydac or 11793 Waters Chromatography Div.,
Milford, MA) with detection by absorbance at 214 nm. Molecular mass
was determined by fast atom bombardment mass spectroscopy (FAB/
MS) using a VG 70 SEQ tandem hybrid instrument (VG Analytical,
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Altringham, UK). Amino acid composition was determined by the
Waters Pico-Tag method after 24 h vapor phase acid hydrolysis
(Bidlingmeyer et al., 1984). In some cases, electron probe x-ray
microanalysis (EPXMA; Johnson and Cantino, 1986) and "F-NMR
were performed to assay for contaminants. We found that RP-HPLC
purification of the starting material not only removed contaminating
peptide sequences and other synthesis byproducts but also removed
inorganic material, including silicon, fluoride, and aluminum, from
peptides synthesized by the t-Boc strategy. Aluminofluoride at concen-
trations comparable to that found in some unpurified peptides
markedly inhibited force production (Chase and Kushmerick, 1990).
Myofibrils
Myofibrils were made from glycerinated psoas muscle from rabbit
(Knight and Trinick, 1982). Muscle strips were tied to wooden sticks at
in vivo length and immersed in chilled myofibril glycerinating buffer
(13.3 mM KH2PO4, pH 7.0 at 0'C, mixed 1:1 with glycerol); after 1 h,
the muscle strips were transferred to fresh myofibril glycerinating
buffer and stored at -20°C. To make myofibrils, a muscle strip was
minced in 10 vol of ice cold myofibril rigor buffer (in mM; 100 KCl, 2
Mg(CH3CO2)2, 1 EDTA, 10 H3PO4, 0.5 DTT, pH 7.0 at 0'C) and then
homogenized. The homogenate was centrifuged at 2,500 g, the
supernatant discarded, and the pellet resuspended in myofibril rigor
buffer; centrifugation and resuspension were repeated three times.
Myofibrils were mixed with an equal volume of chilled glycerol and
stored at -20'C for up to 8 mo. Protein concentration was determined
from the absorbance at 280 nm of an aliquot of myofibrils dissolved in
1% Na-lauryl sulfate (SDS) (corrected for scattering by subtraction of
the absorbance at 310 nm), using an extinction coefficient of 0.7
ml-mg-' . cm'.
Myofibrillar ATPase activity was determined by the pH-stat method
(White, 1982) using an autotitrator (Radiometer America, Cleveland,
OH). Solutions and conditions for myofibrillar ATPase determinations
were essentially identical to those used for fiber experiments, except
that the pH buffer concentration was reduced to 5 mM. The titrant (in
mM; 5 KOH and 195 KCl) was degassed and kept under CO2
adsorbant. ATPase rate per myosin S1 was calculated by assuming 0.82
p,mol myosin/g of myofibrillar protein (Yates and Greaser, 1983) and a
stoichiometry of 0.58 mol H+ released per mol ATP hydrolyzed (pH
7.1).
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FIGURE 1 Synthetic peptides derived from the MHC sequence around
SH, reversibly inhibited maximum Ca-activated force of skinned
muscle fibers. (A ) Original force record demonstrating inhibition of
force in the presence of peptide. Calibrations: force, 20 mg; time, 1
min. At the arrow, the solution was changed from relaxing (pCa 8) to
activating (pCa 4.5). Transients in the force record result from
periodic length releases followed by restretch (see Methods). The bar
beneath the record indicates the period during which 3.4 mM peptide
IRIPRKG was present in activating solution. The inhibitory properties
of other peptides were qualitatively similar to that shown. (B)
Steady-state isometric force of single skinned fibers from rabbit psoas
muscle in the presence of IRICRKG was normalized to the average of
bracketing contractions in the absence of peptide (0), as shown in A.
Each point represents a single determination. The line was drawn
according to the least squares regression on the data for the equation
y = 1-k .x(k = 0.130; 0.007 SE).
sequence IRICRKG, were used to test the extent to
which the peptide's amino acid sequence specified its
inhibitory properties. The first was the very highly
conserved 16 amino acid sequence around and including
RESULTS
Maximum Ca-activated force of skinned fibers from
rabbit psoas muscle was reversibly inhibited in the
presence of a synthetic peptide with the sequence
IRICRKG with an apparent K5 of -4 mM (Fig. 1). V/,,
of skinned fibers and MgATPase activity of fully Ca-
activated myofibrils were also inhibited by purified
peptide IRICRKG, although the apparent KO5's were
both higher than for inhibition of force (Fig. 2). The shift
between the isometric force and V.,, curves (Figs. 1 and
2) is a real difference because both measurements were
made on each fiber during the same activation by
calcium. Isometric force was obtained from the force
level at the beginning of the digitized slack test records,
before the slack release of the fiber, which allowed an
unambiguous determination of the force baseline.


















FIGURE 2 Unloaded shortening velocity of single skinned fibers (0)
and maximum Ca-activated ATPase activity of myofibrils (A) were
inhibited by synthetic peptide IRICRKG. V,, (0), measured during
the same activations as isometric force determinations (Fig. 1), was
normalized to the average of bracketing contractions in the absence of
peptide (0). Myofibrillar ATPase activity (A), measured by the
pH-stat method, was normalized to the average of four determinations
made in the absence of peptide for comparison with fiber force and V.
measurements. Each point represents a single determination. The line
was redrawn from Fig. 1 B.
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SH2 and SH1 (Ac-CNGVLEGIRICRKGFP-NH2) (El-
zinga and Collins, 1977; Warrick and Spudich, 1987). It
was expected that the longer peptide might have greater
affinity for actin and that chemically blocking the charged
ends might further enhance any correspondence to the
native MHC structure induced by binding of the peptide
to actin. But the apparent Ko0 derived from force
measurements on skinned fibers was similar to that for
the heptapeptide (Fig. 3). Proline, substituted for cys-
teine (IRIPRKG), was expected to disrupt any induced
structure in the peptide. Again, there was no substantial
change in the apparent Kos obtained from the skinned
fiber assay (Fig. 3). The third peptide we used had the
same seven amino acids as the native heptapeptide, but
in a scrambled order (RICIRGK). If the native se-
quence peptide truly mimicked an actin-binding func-
tion of this highly conserved region of MHC, then
reordering the residues should render it less effective.
Again, the apparent KO5 of force inhibition was 4 mM
(Fig. 3). We obtained a small but significant difference
between IRICRKG (Fig. 1) and the "blocked" heptapep-
tide, Ac-IRICRKG-NH2 (KO5 6 mM; Fig. 4), which
was used as the control sequence for the experiments
shown in Figs. 4-6. However, for comparison between
peptides, it is important to note that the data presented
in Figs. 1-3 were obtained during one series of experi-
ments, whereas the data shown in Figs. 4-6 were
collected during a second series. We concluded that the
inhibition of force by these peptides does not depend on
a specific coding of information in the amino acid
sequence. The common feature of these five peptides is
that they all have the same net charge (3+).
To determine whether the net charge of the peptides
influenced their inhibitory properties, two other pep-
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FIGURE 3 Inhibition of maximum Ca-activated force by synthetic
peptides Ac-CNGVLEGIRICRKGFP-NH2 (O), IRIPRKG (A), and
RICIRGK (V). Steady state isometric force of single skinned fibers
from rabbit psoas muscle was normalized to the average of bracketing
contractions in the absence of peptide (0). Each point represents a
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FIGURE 4 Inhibition of maximum Ca-activated force by synthetic
peptides IRICRKG-NH2 (O), Ac-IRICRKG-NH2 (0), and IE-
ICRKG (A). Steady-state isometric force of single skinned fibers from
rabbit psoas muscle was normalized to the average of bracketing
contractions in the absence of peptide (0). Each point represents a
single determination. The line was drawn according to the least
squares regression on the data from peptide Ac-IRICRKG-NH2 (0)
for the equationy = 1 - k * x(k = 0.084; 0.003 SE).
more effective inhibitor of force than the native se-
quence peptide, while peptide IEICRKG (net charge
1+) was less effective (Fig. 4). Chemically blocking only
the COOH-terminus (IRICRKG-NH2), thus increasing
the net charge on the peptide by 1+, resulted in greater
inhibition at lower concentrations when compared with
either Ac-IRICRKG-NH2 (Fig. 4) or IRICRKG (Fig. 1).
The significance of the difference between peptides of
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[Ac-Ile-Arg-Ile-Cys-Arg-Lys-Gly-NH2] (mM)
FIGURE 5 Inhibition of maximum Ca-activated force by synthetic
peptide Ac-IRICRKG-NH2 at ionic strengths 100 mM (C]), 150 mM
(O), and 200 mM (0). Steady-state isometric force of single skinned
muscle fibers was normalized to the average of bracketing contractions
in the absence of peptide and at the same ,u (0). As shown in the inset,
force (in the absence of peptide) increased as A. was decreased; in the
inset, force was normalized to the average of bracketing contractions
at p. = 200 mM (A). Ionic strength was varied by changing the
concentration of Tris cation and CH3COO- anion. Points are the
mean SD (N = 3 in the main figure;N = 12 in the inset). For clarity,
the abscissa was shifted by -0.25 mM for the data at p. = 100 mM, and
by 0.25 mM for the data at p = 200 mM. All lines were drawn to
connect the points.
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[Ile-Arg-nle-Thr-Arg-Lys-Gly] (mM)
FIGURE 6 Inhibition of maximum Ca-activated force by synthetic
peptide IRITRKG in the presence (0) and absence (l) of DTT (50
mM). Steady-state isometric force of single skinned muscle fibers was
normalized to the average of bracketing contractions in the absence of
peptide and at the same concentration of DTT (0). Each point
represents a single determination. The line was redrawn from Fig. 4.
three different peptides were tested on each fiber shown
in Fig. 4. Thus, cationic SH, peptides inhibited maxi-
mum Ca-activated force in a manner that depended on
the charge of the peptide; more positively charged
peptides were more effective inhibitors.
Lowering ionic strength from 200 mM to 150 or 100
mM by reducing the concentrations of Tris+ and
CH3COO- did not alter the inhibitory effects of the
native sequence peptide (Fig. 5). Note that in Fig. 5, all
force values have been scaled to the control force at the
same p,; the decrease of control force with increased p,
obtained in this set of experiments is shown in the inset.
While there was no difference in the normalized data at
the three ,u's, the observed change in absolute force
obtained at a given peptide concentration was greater at
the lower ,u's due to the higher absolute force. It is clear
that the ionic strength contribution of the peptide (and
its associated anion) is not sufficient to explain its
inhibitory activity. For example, 4 mM of a trivalent ion
(with three monovalent counterions) would increase p,
by 24 mM. This would correspond to, at most, an 11%
decrease in force (Fig. 5, inset), whereas the actual
decrease was 33 to 50%. In addition, the actual contribu-
tion to p of a peptide with net charge 3+ is probably less
than that of a trivalent ion.
We examined the effects of a peptide in which
threonine was substituted for cysteine as a control for
disulfide bond formation, either between peptides (di-
peptide formation) or between peptides and the native
contractile proteins, which might have occurred despite
the use of a reducing agent. This variation in sequence
occurs naturally in an invertebrate myosin (Warrick et
al., 1986). The Cys-+Thr substituted peptide also inhib-
ited force, as did the native sequence peptide (Fig. 6).
The inhibition was not significantly different in the
presence or absence of DTT (Fig. 6), demonstrating that
inclusion of DTT in the bathing solutions did not
unexpectedly modify the previous results.
DISCUSSION
Peptides with sequences derived from the MHC primary
sequence around SH, reversibly inhibited maximum
Ca-activated force production and unloaded shortening
velocity of skinned fibers from rabbit psoas muscle, and
also inhibited maximum Ca-activated myofibrillar
ATPase activity. Although these results coincide with
predictions for a site-specific inhibitor of the actomyosin
interaction (Keane et al., 1990; Suzuki et al., 1987), the
fact that force inhibition depended on the peptide's net
charge rather than on the specific sequence of amino
acids leads us to conclude the opposite. Our data do not
support the hypothesis that these peptides from the
region of SH, are structurally specific inhibitors of the
force-generating interaction between myosin and actin,
and thus do not support the inference that the SHI
region is an essential part of the interface with actin.
This interpretation contrasts markedly with the conclu-
sion of recent studies involving SH, peptides that the
function (or functions) of the SH, region ofMHC entails
binding to actin (Suzuki et al., 1987; Suzuki et al., 1990;
Keane et al., 1990; Eto et al., 1990).
Previous work suggested that SH, is at or near the
interface with actin, although the functional significance
of the proposed interaction differs. Morita and co-
workers postulated that SH, is part of the strong-binding
site (the "S-site", which corresponds to residues 702-
708 of the numbering scheme used by Keane et al., 1990;
Suzuki et al., 1987; Suzuki et al., 1990; Eto et al., 1990).
According to Trayer and co-workers (Keane et al.,
1990), the residues immediately adjacent to the SH, Cys
(residues 687-717 according to the same numbering
scheme) were proposed to be directly involved in modu-
lation of thin filament Ca-sensitivity (Keane et al., 1990).
Peptide Y669 (comprised of residues 706-715 according
to the same numbering scheme) was particularly effec-
tive at enhancing Ca-sensitivity ofboth regulated acto-Sl
ATPase and skinned fiber force. A second overlapping
region, comprising the SH, Cys and additional COOH-
terminal residues, was also proposed to be part of the
actomyosin interaction which is central to acto-Si
ATPase activity (Keane et al., 1990). Although Keane et
al., also noted some inhibition of skinned fiber force
development by the same peptides, the results were not
presented in detail. Our primary experimental goal was
to probe the force-generating interface between myosin
and actin, and thus, the majority of experiments were
carried out using fully Ca-activated skinned fibers.
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Maximum Ca-activated force was chosen as the primary
indicator because peptide binding to a myosin contact
site on actin should reduce the force-generating poten-
tial with the magnitude of the effect being proportional
to the number of force-generating cross-bridges, which is
greatest at full Ca-activation. The control peptides used
for the conclusions of Keane et al. (1990) and the initial
conclusions of Suzuki et al. (1987, 1990) were based on
sequences derived from adjacent regions of MHC. Our
data suggest that this may not be sufficient to discrimi-
nate functional regions of primary sequence, and that
SH1 is not part of the force-generating interface between
myosin and actin. Therefore, we also suggest that any
role for SH1 in modulating the cooperativity of ATPase
and force development at submaximal [Ca2"] should be
regarded as speculative until appropriate controls for
sequence specificity are made.
Peptides appear to be less effective inhibitors in fiber
and myofibril assays than in assays conducted with
purified proteins. The apparent inhibitory constant ob-
tained in this work (4-6 mM for skinned fiber force)
differed significantly from that obtained in solution by
Suzuki et al. (230 puM for rigor binding, Suzuki et al.,
1987; 47 puM for actin-activated MgATPase activity,
Suzuki et al., 1990), although peptides with the same
sequence were used in all of these studies. This differ-
ence of 1-2 orders of magnitude was not due to
differences in charges at the ends of the peptides
(compare Figs. 1 and 4). Additional protein (BSA or
CK) was present in both experiments, which would
compensate for nonspecific protein binding and counter-
act the possible influence of any endogenous proteolytic
enzymes that may have remained in the preparation (we
also included trypsin inhibitor in the dissection bath,
although for a different reason: see Methods). Differ-
ences in ionic strength do not seem likely to be the
complete explanation since the apparent Os5 of the
peptide in our assays was not altered when ,u was
lowered from 200 to 100 mM, which is slightly lower than
,u used in the rigor binding assays (Suzuki et al., 1987),
although it is not as low as that used in the ATPase
assays with purified proteins (Suzuki et al., 1990). Other
related peptides were tested by Keane et al. (1990) using
both solution assays and fiber assays. Apparent inhibi-
tory Ko5's for the fiber work were not given, but compar-
ing two peptides common in both of their Figs. 3 and 4
(peptides Y629 and Y630) indicates that at least an
order of magnitude higher peptide concentration was
required for half-maximal inhibition of maximum Ca-
activated force in skinned fibers compared with that
necessary to inhibit acto-Sl ATPase activity. The fact
that analogous results were obtained with various pep-
tide sequences in different laboratories suggests that the
quantitative difference between peptide effects on puri-
fied proteins vs. in fibers is a valid observation that is not
yet explained. A difference in the major anion (acetate
in our experiments, whereas Suzuki et al. [1987, 1990]
used chloride) does not seem to be the likely causal
factor, in spite of destabilization of myosin structure by
Cl- that occurs at much higher [Cl-I (Stafford, 1985),
because Keane et al. (1990) used Cl- in all of their
experiments. The use of purified proteins and protein
fragments to examine the actomyosin interaction in
solution confines the investigation to that interface
which exists under essentially "unloaded" conditions
(Suzuki et al., 1987, 1990; Keane et al., 1990; Eto et al.,
1990). The "unloaded" nature of the actomyosin interac-
tion in the solution assays cannot explain the difference
because peptide inhibition of both V11, of fibers and
ATPase activity of myofibrils had a higher, rather than
lower, apparent K5 than force inhibition. Furthermore,
the charge of the intact myofibrillar structure cannot be
responsible for the difference because the negative
Donnan potential of fibers and myofibrils would result in
an elevated concentration of cationic peptide within the
fiber lattice relative to the bath concentration, which
should have given an apparent lowering of KY,% in fibers
and myofibrils compared with proteins in solution.
Overall, these results suggest significant unexplained
differences may exist between the mechanically uncon-
strained interaction between the purified contractile
proteins in solution and the actomyosin interaction
within the myofilament lattice.
The involvement of charge in the inhibitory mecha-
nism of SH, peptides should not be surprising in light of
the well-known part played by ionic interactions in
cross-bridge function (e.g., Katoh and Morita, 1984;
Sutoh, 1982; Gordon et al., 1973). Also, numerous
nonpeptide inhibitors of the actomyosin interaction,
including salts, have been identified; even uncharged
molecules such as 2,3-butanedione monoxime and su-
crose inhibit force and velocity of skinned fibers (Fryer
et al., 1988; Chase and Kushmerick, 1988a), although
inhibitory sucrose concentrations were two orders of
magnitude higher than the concentrations of peptides
used in these experiments. We noted that there was also
a correlation between inhibition of actin-activated
MgATPase activity of S1 and net peptide charge in the
data of Keane et al. (1990). In their paper, those
peptides which were most inhibitory were synthesized
according to the MHC sequence including and immedi-
ately adjacent to the SHR cysteine and were purified
using gel filtration and ion-exchange chromatography;
those which were least inhibitory came from the se-
quence flanking the SH, region and were purified by
RP-HPLC. Purification methods could conceivably make
a difference because, in our work, we found that inor-
ganic contaminants significantly altered the apparent
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K35 (Chase and Kushmerick, 1989, 1990; Chase and
Kushmerick, 1988b), but the major correlating prop-
erty was charge. Within the former (inhibitory) group
of peptides studied by Keane et al. (1990), the
most inhibitory peptide, GIRICRKGFPSRILYAD-
FKQRYKVLNAS (Y630; the SH1 Cys is bolded for
reference), had a net charge of 6+, assuming that both
the NH2- and COOH-termini were chemically blocked
or both were free. The least inhibitory peptide of this
group, GVLEGIRICR (Y668; the SH1 Cys is bolded for
reference), had a net charge of 1+. Peptides with charges
2+ to 3+ had intermediate inhibitory effects. The latter
"flanking" peptides, which were the least inhibitory of
all, had net charges of 1- to 1+. Suzuki et al. (1990) also
examined the effects of two peptides on actin-activated
MgATPase activity of Si; in their data, the longer SH1
peptide, with a net charge of 4+, was inhibitory at lower
concentrations than the second, shorter peptide with a
net charge of 2+. Despite the correlation between charge
and inhibition of actively cycling cross-bridges, inhibi-
tion of rigor complex formation between actin and S1
was demonstrated to depend on amino acid composition
more than net peptide charge of peptides with variations
in individual amino acids (Eto et al., 1990).
The high sequence homology of the SH1 region in
myosins from a wide variety of organisms (Stedman et
al., 1990; Warrick and Spudich, 1987), combined with
the extensive literature on the biochemistry of SH1,
justify the supposition that it has an important role in
myosin function. Our data do not support an actin-
binding role for the SH1 region as a necessary part of
cross-bridge function. Further tests should therefore be
focused on alternative possibilities for the function of
the SH1 region of myosin and on which portions of the
MHC primary sequence are involved in binding to actin.
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